Myriad RBM’s DiscoveryMAP® Identifies a Protein Biomarker Panel for Bipolar Disorder
Researchers at the Mayo Clinic used Myriad RBM’s Multi-Analyte Profile (MAP) platform to analyze 320 serum proteins in healthy control subjects and su...
Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia
An international team of researchers used Myriad RBM’s Multi-Analyte Profile (MAP) technology to identify a pattern of cardiometabolic biomarkers that...
Use of biomarkers to guide immunotherapy drug development
VentiRx, the developers of motolimod, a TLR8 agonist, have published preclinical and clinical results that indicate effective immune system stimulatio...
Blood-based biomarkers show promise as an early diagnostic tool for RA-ILD
Researchers at Brigham and Women’s Hospital, Harvard Medical School demonstrate the utility of a blood-based panel for identifying Interstitial Lung D...
Prototypic modified risk tobacco product reduces cigarette smoke induced inflammation and COPD symptoms in mice
Researchers at Philip Morris used Myriad RBM’s RodentMAP (Multi-Analyte Profiling) immunoassay service and other histological and functional assessmen...
Pharmacodynamic biomarkers for Apremilast treatment in psoriatic arthritis
A new paper from Peter Schafer, et al, of Celgene shows how biomarkers can be used to monitor treatment response in an inflammatory disease setting. T...
ENRAGE: A Novel Inflammatory Marker for Incident Coronary Heart Disease
This recent paper in the Arteriosclerosis, Thrombosis and Vascular Biology Journal of the American Heart Association describes an interesting prospect...